Target
Cyclin-dependent kinase 9
Ligand
BDBM316190
Substrate
n/a
Meas. Tech.
Fluorescent Polarization Assay
IC50
<1000±n/a nM
Citation
 Lori, FChafouleas, JDe Forni, DSolinas, AVarga, ZGreff, ZÖrfi, LKéri, G 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity US Patent  US9617225 Publication Date 4/11/2017 
Target
Name:
Cyclin-dependent kinase 9
Synonyms:
C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit
Type:
Enzyme Subunit
Mol. Mass.:
42789.13
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
372
Sequence:
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF
  
Inhibitor
Name:
BDBM316190
Synonyms:
US10294218, Example 18 | US9617225, Example 18 | ethyl 5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-morpholinobenzoate
Type:
Small organic molecule
Emp. Form.:
C24H26N4O4
Mol. Mass.:
434.4876
SMILES:
CCOC(=O)c1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1N1CCOCC1
Structure:
Search PDB for entries with ligand similarity: